The single most immediate and severe threat to General Mills' gross margins and operating income is the rapid proliferation of GLP-1 receptor agonist weight-loss drugs (such as Ozempic, Wegovy, and Mounjaro), which have been clinically shown to reduce appetite, decrease food cravings, and specifically reduce the consumption of high-calorie, high-carbohydrate 'hedonic' foods like cereal, baked goods, and snacks, the exact core categories that account for over 60% of General Mills' North America Retail revenue. While General Mills' internal consumer panel data in FY2024 showed only a minimal impact (a 0.8% volume decline among self-reported GLP-1 users), the long-term structural risk is severe; if GLP-1 penetration reaches 15-20% of the adult population in the US by 2030, as projected by Goldman Sachs, it could result in a permanent 4-6% reduction in total addressable market volume for sweet snacks and traditional cereals, forcing General Mills to aggressively pivot its R&D and M&A strategy toward high-protein, low-sugar, and health-adjacent categories (like the EPIC Provisions acquisition) to offset the structural decline in its core franchises. A second, highly specific threat to General Mills' long-term volume growth is the aggressive expansion of private-label (store-brand) competitors in North American retail, driven by the cost-of-living crisis that has made consumers highly price-sensitive. Retailers like Aldi, Walmart (Great Value), and Kroger have significantly improved the quality of their private-label cereal and snacking offerings, often manufacturing them in the same facilities as national brands, and are pricing them at a 25-30% discount to General Mills' core SKUs. In the US ready-to-eat cereal category, the private-label share of the market increased by 180 basis points in FY2024, directly at the expense of General Mills' Cheerios and Honey Nut Cheerios brands, forcing the company to increase trade promotion spend and implement temporary price rollbacks to defend market share, a strategy that compresses gross margins and sets a dangerous precedent for future pricing power. A third, structural challenge is the ongoing, secular decline of the traditional ready-to-eat (RTE) cereal category, which has been in a multi-year structural decline due to the shift toward on-the-go breakfast occasions, the rise of high-protein breakfast alternatives (like Greek yogurt and protein bars), and the increasing consumer perception that traditional cereals are too high in sugar. General Mills' RTE cereal volumes have declined by an average of 2.5% annually over the last five years, and despite attempts to reposition cereal as a 'snacking' occasion (with the launch of Cheerios Dips and cereal-flavored snacks), the company has been unable to reverse the secular decline in the traditional breakfast aisle, forcing it to accept the category as a 'cash cow' that requires minimal marketing investment while it generates steady cash flow to fund growth in the pet and snacking categories. A fourth challenge is the extreme volatility in input costs, particularly in dairy, cocoa, and specific grains, which are subject to significant price swings due to weather patterns, geopolitical events, and currency fluctuations. In FY2024, the cost of block cheese and whey powder (critical for pet food and snacking) increased by 18% year-over-year, while the cost of cocoa (critical for baking and confectionery) surged by 45%, forcing General Mills to absorb significant unhedged costs in the second half of the fiscal year and compressing gross margins by 150 basis points despite aggressive price increases on core SKUs.